Literature DB >> 9469312

Total knee arthroplasty in patients who have pigmented villonodular synovitis.

B R Hamlin1, G P Duffy, R T Trousdale, B F Morrey.   

Abstract

We reviewed the results of all eighteen total knee arthroplasties that had been performed at the Mayo Clinic between 1974 and 1992 for the treatment of pigmented villonodular synovitis. The diagnosis had been confirmed histologically in all patients. Fourteen patients had diffuse disease, which was active in eleven and inactive in three, and four had focal disease. In addition to the arthroplasty, the eleven patients who had active diffuse disease were managed with a complete synovectomy and the four patients who had focal disease had a partial synovectomy. The three remaining patients had a history of diffuse pigmented villonodular synovitis but had no evidence of disease at the time of the arthroplasty, so a synovectomy was not performed. At an average of 9.9 years (range, 3.6 to 20.1 years) after the arthroplasty, fourteen of the eighteen total knee prostheses were well fixed and functioning satisfactorily. The average knee score was 89 points (range, 80 to 99 points) and the average functional score was 77 points (range, 20 to 100 points) for these fourteen patients. The four failures were in patients who had active diffuse disease at the time of the arthroplasty. Three of the failures were due to aseptic loosening, and one was due to recurrence of the disease. Sixteen patients had no evidence of recurrence when they were last seen, at an average of 10.3 years (range, 3.6 to 20.1 years) after the arthroplasty. The two patients who had a recurrence were among the eleven who had active diffuse disease. In one of these patients, the recurrence was diagnosed at the time of a revision arthroplasty performed because of aseptic loosening. The other patient had two recurrences, necessitating an above-the-knee amputation.

Entities:  

Mesh:

Year:  1998        PMID: 9469312     DOI: 10.2106/00004623-199801000-00013

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  11 in total

1.  Unusual cases of pigmented villonodular synovitis after arthroplasty.

Authors:  Xiao-Mei Ma; Chun-Yan Xia; Pei-Liang Fu; Hui-Min Liu; Hong-Yu Yu; Jin He
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients.

Authors:  Lizz van der Heijden; Sheila R Piner; Michiel Adrianus Josephus van de Sande
Journal:  Int Orthop       Date:  2016-05-12       Impact factor: 3.075

3.  [Bone transplantation with total hip endoprosthesis for diffuse pigmented villonodular synovitis].

Authors:  C Friesecke; R Granes; N Siemssen
Journal:  Orthopade       Date:  2013-10       Impact factor: 1.087

4.  Arthroplasty for tenosynovial giant cell tumors.

Authors:  Floortje G M Verspoor; Gerjon Hannink; Anouk Scholte; Ingrid C M Van Der Geest; H W Bart Schreuder
Journal:  Acta Orthop       Date:  2016-06-30       Impact factor: 3.717

5.  Total knee replacement in patients with diffuse villonodular synovitis.

Authors:  Lucio Flávio Biondi Pinheiro Junior; Marcos Henrique Frauendorf Cenni; Rafael Henriques Soares Leal; Luiz Eduardo Moreira Teixeira
Journal:  Rev Bras Ortop       Date:  2017-08-14

6.  Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases.

Authors:  Monique J L Mastboom; Floortje G M Verspoor; Hans Gelderblom; Michiel A J van de Sande
Journal:  Case Rep Orthop       Date:  2017-06-28

7.  Treatment of Recurrent Hemarthrosis after Total Knee Arthroplasty.

Authors:  Ju-Hyung Yoo; Hyun-Cheol Oh; Sang-Hoon Park; Sanghyeon Lee; Yunjae Lee; Seong-Hun Kim
Journal:  Knee Surg Relat Res       Date:  2018-06-01

8.  Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.

Authors:  Akihiko Takeuchi; Akihiro Nomura; Norio Yamamoto; Katsuhiro Hayashi; Kentaro Igarashi; Susumu Tandai; Akira Kawai; Akihiko Matsumine; Shinji Miwa; Yoshihiro Nishida; Tomoki Nakamura; Ryu Terauchi; Manabu Hoshi; Toshiyuki Kunisada; Makoto Endo; Kenichi Yoshimura; Toshinori Murayama; Hiroyuki Tsuchiya
Journal:  BMC Musculoskelet Disord       Date:  2019-02-09       Impact factor: 2.362

9.  Treatment of Recurrent Hemarthrosis Following Total Knee Arthroplasty Using Surgical Interventions.

Authors:  Keun Ho Park; Dong Hwi Kim; Se Woong Jang; Je Hong Ryu; Kang Yeol Ko
Journal:  Clin Orthop Surg       Date:  2021-04-01

10.  Pigmented villonodular synovitis does not influence the outcomes following cruciate-retaining total knee arthroplasty: a case-control study with minimum 5-year follow-up.

Authors:  Wei Lin; Yike Dai; Jinghui Niu; Guangmin Yang; Ming Li; Fei Wang
Journal:  J Orthop Surg Res       Date:  2020-09-07       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.